THC Gummies Raise Questions Medicine Can’t Answer Alone
Budpop gummies and similar tetrahydrocannabinol-infused confections present unprecedented bioethical challenges that extend far beyond traditional pharmaceutical ethics. The candy-like format of these products creates unique tensions between therapeutic legitimacy and recreational appeal, raising critical questions about medicalization, patient autonomy, and societal responsibility that demand rigorous examination through interdisciplinary bioethics research.
The gummy delivery system fundamentally alters the ethical landscape of cannabis consumption. Unlike smokable cannabis or …

